The MarketWatch News Department was not involved in the creation of this content. Landmark study demonstrates safety and performance of the eShunt System in the treatment of communicating ...
BOSTON, Oct. 3, 2023 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced a milestone thirtieth patient received ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The FDA has granted 510(k) clearance to a ...